Grown Rogue International (GRUSF) Depreciation & Amortization - Total (2009 - 2021)

Grown Rogue International's (GRUSF) quarterly Depreciation & Amortization - Total came in at $195975.4 in Q2 2021, up 4462.13% quarter-over-quarter from $4295.7 in Q4 2011.

Grown Rogue International (GRUSF) Depreciation & Amortization - Total (2009 - 2021) Analysis & Trends

Grown Rogue International's Depreciation & Amortization - Total history runs 4 years deep, the most recent figure standing at $195975.4 for Q2 2021.

  • On a quarterly basis, Depreciation & Amortization - Total changed N/A year-over-year to $195975.4 in Q2 2021; TTM through Jan 2022 was $195975.4, a N/A change from a year earlier, with the FY2011 full-year figure at $23389.4, down 36.59% from the prior year.
  • Depreciation & Amortization - Total climbed to $195975.4 in Q2 2021 per GRUSF's latest filing, from $4295.7 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $195975.4 in Q2 2021 and bottomed at $195975.4 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2021 195,975.44
Nov 30, 2011 4,295.70
Aug 31, 2011 6,054.10
May 31, 2011 5,815.97
Feb 28, 2011 5,896.86
Nov 30, 2010 5,614.43
Aug 31, 2010 12,041.78
May 31, 2010 6,685.69
Feb 28, 2010 8,790.06
Nov 30, 2009 9,172.08
Aug 31, 2009 16,521.15
May 31, 2009 6,652.88
Feb 28, 2009 129.82